Novoprotein announced that as of March 2025, the company has repurchased a total of 2,000 shares through centralized bidding transactions, accounting for 0.0028% of the company's total share capital, with the highest purchase price at RMB 35.51 per share and the lowest price at RMB 35.51 per share, totaling RMB 71,022.41. As of March 31, 2025, the company has repurchased a total of 360,300 shares for the employee stock ownership plan or equity incentive through the Shanghai Stock Exchange's centralized bidding system, accounting for 0.5135% of the company's total share capital, with the highest transaction price at RMB 35.51 per share, the lowest price at RMB 28.75 per share, and a total payment of RMB 10.6684 million. The repurchase plan aimed at stabilizing the stock price and legally canceling and reducing registered capital has not yet been implemented
